New evidence suggests that the mechanism of nanoparticle entry into solid tumours may be driven by an active process. This insight paves the way for approaches to enhance the efficiency of nanomedicine delivery by harnessing active transport mechanisms, and encourage researchers to rethink how tumours are treated.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Editorial of Special Issue “Cytoplasmic Delivery of Bioactives”
Pharmaceutical Research Open Access 23 May 2022
-
Active targeting via ligand-anchored pH-responsive strontium nanoparticles for efficient nucleic acid delivery into breast cancer cells
Journal of Pharmaceutical Investigation Open Access 25 January 2022
-
Peptide-based semiconducting polymer nanoparticles for osteosarcoma-targeted NIR-II fluorescence/NIR-I photoacoustic dual-model imaging and photothermal/photodynamic therapies
Journal of Nanobiotechnology Open Access 21 January 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Chan, W. C. W. Acc. Chem. Res. 50, 627–632 (2017).
Nakamura, H., Jun, F. & Maeda, H. Expert Opin. Drug Deliv. 12, 53–64 (2015).
Wilhelm, S. et al. Nat. Rev. Mater 1, 16014 (2016).
Shi, J., Kantoff, P., Wooster, R. & Farokhzad, O. C. Nat. Rev. Cancer 17, 20–37 (2017).
Sindhwani, S. et al. Nat. Mater. https://doi.org/10.1038/s41563-019-0566-2 (2020).
Hobbs, S. K. et al. Proc. Natl Acad. Sci. USA 95, 4607–4612 (1998).
Schnitzer, J. E. Am. J. Physiol. Heart Circ. Physiol. 262, H246–H254 (1992).
Dvorak, H. F., Nagy, J. A., Dvorak, J. T. & Dvorak, A. M. Am. J. Pathol. 133, 95–109 (1988).
Oh, P. et al. Nat. Med. 20, 1062–1068 (2014).
Liu, Y. et al. Nano Lett. 19, 8010–8020 (2019).
Detampel, P. et al. PloS ONE 14, e0223339 (2019).
Ayloo, S. & Gu, C. Curr. Opinion Neurobiol. 57, 32–38 (2019).
Wiley, D. T., Webster, P., Gale, A. & Davis, M. E. Proc. Natl Acad. Sci. USA 110, 8662–8667 (2013).
Zhou, Q. et al. Nat. Nanotechnol. 14, 799–809 (2019).
Ruan, G., Agrawal, A., Marcus, A. I. & Nie, S. J. Am. Chem. Soc. 129, 14759–14766 (2007).
Ruoslahti, E. Adv. Drug Deliv. Rev. 110–111, 3–12 (2017).
Schmid, D. et al. Nat. Commun. 8, 1747 (2017).
Ledford, H. Nature 497, 544–544 (2013).
Syn, N. L., Teng, M. W. L., Mok, T. S. K. & Soo, R. A. Lancet Oncol. 18, e731–e741 (2017).
Jiang, W. et al. Nat. Biomed. Eng. 1, 0029 (2017).
Reinhard, K. et al. Science 367, 446–453 (2020).
Sahin, U. et al. Nature 547, 222–226 (2017).
Yuan, H. et al. Nat. Nanotechnol. 12, 763–769 (2017).
Chen, Q. et al. Nat. Commun. 7, 13193 (2016).
Kulkarni, A. et al. Proc. Natl Acad. Sci. USA 113, E2104–E2113 (2016).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pandit, S., Dutta, D. & Nie, S. Active transcytosis and new opportunities for cancer nanomedicine. Nat. Mater. 19, 478–480 (2020). https://doi.org/10.1038/s41563-020-0672-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41563-020-0672-1
This article is cited by
-
Hybrid transcytosis nanopomegranates for sensitizing breast cancer radiotherapy in deep tumor tissue
Nano Research (2023)
-
Peptide-based semiconducting polymer nanoparticles for osteosarcoma-targeted NIR-II fluorescence/NIR-I photoacoustic dual-model imaging and photothermal/photodynamic therapies
Journal of Nanobiotechnology (2022)
-
Design of therapeutic biomaterials to control inflammation
Nature Reviews Materials (2022)
-
Editorial of Special Issue “Cytoplasmic Delivery of Bioactives”
Pharmaceutical Research (2022)
-
Active targeting via ligand-anchored pH-responsive strontium nanoparticles for efficient nucleic acid delivery into breast cancer cells
Journal of Pharmaceutical Investigation (2022)
